LAURA MONAGHAN: Open Payments
NPI 1841927035 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 62 payments from 15 companies in 2025. Trend: 2023 $1,256 · 2024 $1,459 · 2025 $1,700
Food & beverage: $1,525Education: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $330 |
| Novartis Pharmaceuticals Corporation | 4 | $293 |
| GENZYME CORPORATION | 7 | $284 |
| ABBVIE INC. | 12 | $235 |
| Arcutis Biotherapeutics, Inc. | 6 | $121 |
| UCB, Inc. | 3 | $73 |
| PFIZER INC. | 4 | $70 |
| Organon LLC | 5 | $64 |
| Amgen Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $44 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Rhapsido, Zoryve, Bimzelx, CIBINQO, SKYRIZI.
Industry payments across NC — which companies pay providers there.
